131 related articles for article (PubMed ID: 12930152)
1. DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.
Kaizerman JA; Gross MI; Ge Y; White S; Hu W; Duan JX; Baird EE; Johnson KW; Tanaka RD; Moser HE; Bürli RW
J Med Chem; 2003 Aug; 46(18):3914-29. PubMed ID: 12930152
[TBL] [Abstract][Full Text] [Related]
2. DNA binding ligands with improved in vitro and in vivo potency against drug-resistant Staphylococcus aureus.
Hu W; Bürli RW; Kaizerman JA; Johnson KW; Gross MI; Iwamoto M; Jones P; Lofland D; Difuntorum S; Chen H; Bozdogan B; Appelbaum PC; Moser HE
J Med Chem; 2004 Aug; 47(18):4352-5. PubMed ID: 15317448
[TBL] [Abstract][Full Text] [Related]
3. DNA binding ligands targeting drug-resistant Gram-positive bacteria. Part 1: Internal benzimidazole derivatives.
Bürli RW; McMinn D; Kaizerman JA; Hu W; Ge Y; Pack Q; Jiang V; Gross M; Garcia M; Tanaka R; Moser HE
Bioorg Med Chem Lett; 2004 Mar; 14(5):1253-7. PubMed ID: 14980676
[TBL] [Abstract][Full Text] [Related]
4. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
Hadjivassileva T; Thurston DE; Taylor PW
J Antimicrob Chemother; 2005 Sep; 56(3):513-8. PubMed ID: 16024592
[TBL] [Abstract][Full Text] [Related]
5. DNA binding ligands with in vivo efficacy in murine models of bacterial infection: optimization of internal aromatic amino acids.
Bürli RW; Kaizerman JA; Duan JX; Jones P; Johnson KW; Iwamoto M; Truong K; Hu W; Stanton T; Chen A; Touami S; Gross M; Jiang V; Ge Y; Moser HE
Bioorg Med Chem Lett; 2004 May; 14(9):2067-72. PubMed ID: 15080980
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and structure-activity relationship studies of novel indazole analogues as DNA gyrase inhibitors with Gram-positive antibacterial activity.
Tanitame A; Oyamada Y; Ofuji K; Kyoya Y; Suzuki K; Ito H; Kawasaki M; Nagai K; Wachi M; Yamagishi J
Bioorg Med Chem Lett; 2004 Jun; 14(11):2857-62. PubMed ID: 15125947
[TBL] [Abstract][Full Text] [Related]
7. Conformational constraint in oxazolidinone antibacterials. Synthesis and structure-activity studies of (azabicyclo[3.1.0]hexylphenyl)oxazolidinones.
Renslo AR; Jaishankar P; Venkatachalam R; Hackbarth C; Lopez S; Patel DV; Gordeev MF
J Med Chem; 2005 Jul; 48(15):5009-24. PubMed ID: 16033280
[TBL] [Abstract][Full Text] [Related]
8. Potent antibacterial activity of halogenated compounds against antibiotic-resistant bacteria.
Vairappan CS; Kawamoto T; Miwa H; Suzuki M
Planta Med; 2004 Nov; 70(11):1087-90. PubMed ID: 15549668
[TBL] [Abstract][Full Text] [Related]
9. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
[TBL] [Abstract][Full Text] [Related]
10. In vivo antibacterial activity of chinfloxacin, a new fluoroquinolone antibiotic.
Li GQ; Bai XG; Li CR; Yang XY; Hu XX; Yuan M; Zhang WX; Lou RH; Guo HY; Jiang JD; You XF
J Antimicrob Chemother; 2012 Apr; 67(4):955-61. PubMed ID: 22210757
[TBL] [Abstract][Full Text] [Related]
11. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
12. Novel and potent oxazolidinone antibacterials featuring 3-indolylglyoxamide substituents.
Takhi M; Singh G; Murugan C; Thaplyyal N; Maitra S; Bhaskarreddy KM; Amarnath PV; Mallik A; Harisudan T; Trivedi RK; Sreenivas K; Selvakumar N; Iqbal J
Bioorg Med Chem Lett; 2008 Sep; 18(18):5150-5. PubMed ID: 18768315
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of tigecycline against quinolone-resistant Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
Garrison MW; Nuemiller JJ
Int J Antimicrob Agents; 2007 Feb; 29(2):191-6. PubMed ID: 17174074
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and structure-activity relationships of 5-amino-6-fluoro-1-[(1R,2S)-2-fluorocyclopropan-1-yl]-8-methylquinolonecarboxylic acid antibacterials having fluorinated 7-[(3R)-3-(1-aminocyclopropan-1-yl)pyrrolidin-1-yl] substituents.
Inagaki H; Miyauchi S; Miyauchi RN; Kawato HC; Ohki H; Matsuhashi N; Kawakami K; Takahashi H; Takemura M
J Med Chem; 2003 Mar; 46(6):1005-15. PubMed ID: 12620077
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo activities of echinomycin against clinical isolates of Staphylococcus aureus.
Park YS; Shin WS; Kim SK
J Antimicrob Chemother; 2008 Jan; 61(1):163-8. PubMed ID: 17967852
[TBL] [Abstract][Full Text] [Related]
16. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
Namba K; Zheng X; Motoshima K; Kobayashi H; Tai A; Takahashi E; Sasaki K; Okamoto K; Kakuta H
Bioorg Med Chem; 2008 Jun; 16(11):6131-44. PubMed ID: 18468909
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the antibacterial activity of a lead structure discovered by "SAR by MS" technology.
Jefferson EA; Seth PP; Robinson DE; Winter DK; Miyaji A; Risen LM; Osgood SA; Bertrand M; Swayze EE
Bioorg Med Chem Lett; 2004 Nov; 14(21):5257-61. PubMed ID: 15454207
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
Watters AA; Jones RN; Leeds JA; Denys G; Sader HS; Fritsche TR
J Antimicrob Chemother; 2006 May; 57(5):914-23. PubMed ID: 16549511
[TBL] [Abstract][Full Text] [Related]
19. New antibacterial agents derived from the DNA gyrase inhibitor cyclothialidine.
Angehrn P; Buchmann S; Funk C; Goetschi E; Gmuender H; Hebeisen P; Kostrewa D; Link H; Luebbers T; Masciadri R; Nielsen J; Reindl P; Ricklin F; Schmitt-Hoffmann A; Theil FP
J Med Chem; 2004 Mar; 47(6):1487-513. PubMed ID: 14998336
[TBL] [Abstract][Full Text] [Related]
20. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
